Guideline for allergological diagnosis of drug hypersensitivity reactions

Not available.

[1]  J. Bernstein,et al.  Drug Allergy: A 2022 Practice Parameter Update. , 2022, The Journal of allergy and clinical immunology.

[2]  L. Weinhold,et al.  Lymphocyte Transformation Test for drug allergy detection: when does it work? , 2022, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  Philipp Schrüfer,et al.  Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing , 2022, Allergy, Asthma & Clinical Immunology.

[4]  C. Janson,et al.  Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper , 2022, Allergy.

[5]  K. Brockow,et al.  Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions , 2022, Allergologie select.

[6]  A. Muraro,et al.  EAACI guidelines: Anaphylaxis (2021 update) , 2021, Allergy.

[7]  K. Brockow.  Detection of drug-specific immunoglobulin E (IgE) and acute mediator release for the diagnosis of immediate drug hypersensitivity reactions. , 2021, Journal of immunological methods.

[8]  P. Bonadonna,et al.  Hypersensitivity reactions to chemotherapy: an EAACI Position Paper , 2021, Allergy.

[9]  A. Sickmann,et al.  Lymphocyte transformation test: History and current approaches. , 2021, Journal of immunological methods.

[10]  H. Sitter,et al.  Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update , 2021, Allergo Journal International.

[11]  D. Ebo,et al.  Principles, potential and limitations of ex vivo basophil activation by flow cytometry in allergology: a narrative review. , 2020, The Journal of allergy and clinical immunology.

[12]  P. Bonadonna,et al.  Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity , 2020, Allergy.

[13]  A. Trautmann,et al.  De‐labelling antibiotic allergy through five key questions , 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  H. Dickel,et al.  Leitliniengerechte Diagnostik der Kontaktallergie in der Praxis , 2020, Der Hautarzt.

[15]  P. Demoly,et al.  Towards a more precise diagnosis of hypersensitivity to beta‐lactams — an EAACI position paper , 2019, Allergy.

[16]  S. Voltolini,et al.  An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions , 2019, Allergy.

[17]  M. Mockenhaupt,et al.  Making a diagnosis in severe cutaneous drug hypersensitivity reactions. , 2019, Current opinion in allergy and clinical immunology.

[18]  H. Sitter,et al.  Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics , 2019, Allergo Journal International.

[19]  J. Mege,et al.  Paired acute‐baseline serum tryptase levels in perioperative anaphylaxis: An observational study , 2019, Allergy.

[20]  M. Schumacher,et al.  HLA‐B*57:01 confers genetic susceptibility to carbamazepine‐induced SJS/TEN in Europeans , 2019, Allergy.

[21]  M. Triggiani,et al.  Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology. , 2019, The Journal of allergy and clinical immunology.

[22]  W. Aberer,et al.  EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity , 2018, Allergy.

[23]  K. Tenbrock,et al.  Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: a single center experience , 2018, Cutaneous and Ocular Toxicology.

[24]  P. Eigenmann,et al.  Natural History of Benign Nonimmediate Allergy to Beta-Lactams in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test. , 2017, The journal of allergy and clinical immunology. In practice.

[25]  A. Sheikh,et al.  Vaccination and allergy: EAACI position paper, practical aspects , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[26]  P. Demoly,et al.  Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper , 2016, Allergy.

[27]  M. Atanasković-Marković,et al.  Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group , 2016, Allergy.

[28]  K. Brockow,et al.  Pathogenesis of drug allergy – current concepts and recent insights , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  H. Sitter,et al.  Guideline for the diagnosis of drug hypersensitivity reactions , 2015, Allergo Journal International.

[30]  K. Brockow.  Dilemmas of allergy diagnosis in perioperative anaphylaxis , 2014, Allergy.

[31]  A. Barbaud.  Skin Testing and Patch Testing in Non-IgE-Mediated Drug Allergy , 2014, Current Allergy and Asthma Reports.

[32]  P. Demoly,et al.  International Consensus on drug allergy , 2014, Allergy.

[33]  E. Nizankowska-Mogilnicka,et al.  Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs , 2013, Allergy.

[34]  C. Bindslev‐Jensen,et al.  Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge , 2013, Allergy.

[35]  P. Demoly,et al.  Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper , 2013, Allergy.

[36]  Min-Hye Kim,et al.  Clinical value of radiocontrast media skin tests as a prescreening and diagnostic tool in hypersensitivity reactions. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[37]  B. Milpied,et al.  A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions , 2013, The British journal of dermatology.

[38]  D. Ebo,et al.  Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils. , 2012, Journal of immunological methods.

[39]  P. Bousquet,et al.  Evaluating the negative predictive value of provocation tests with nonsteroidal anti‐inflammatory drugs , 2011, Allergy.

[40]  M. Triggiani,et al.  Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal , 2011, International Archives of Allergy and Immunology.

[41]  F. Alla,et al.  Anaphylaxis during anesthesia in France: an 8-year national survey. , 2011, The Journal of allergy and clinical immunology.

[42]  J. Bousquet,et al.  Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA # and GA2LEN/HANNA * , 2011, Allergy.

[43]  G. Porebski,et al.  In vitro diagnosis of T cell‐mediated drug allergy , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[44]  A. Gervaix,et al.  The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge , 2010, Journal of Allergy and Clinical Immunology.

[45]  T. Fuchs,et al.  Hauttests zur Diagnostik von allergischen Soforttypreaktionen , 2010 .

[46]  P. Bousquet,et al.  Determining the negative predictive value of provocation tests with beta‐lactams , 2010, Allergy.

[47]  S. Bello,et al.  Ceftriaxone intradermal test‐related fatal anaphylactic shock: a medico‐legal nightmare , 2010, Allergy.

[48]  M. Blanca,et al.  Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins , 2009, Allergy.

[49]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[50]  T. Fuchs,et al.  Allergologische Diagnostik von Überempfindlichkeitsreaktionen auf Arzneimittel , 2008 .

[51]  C. Bachert,et al.  EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity , 2007, Allergy.

[52]  P. Demoly,et al.  Diagnosis of immediate allergic reactions to beta‐lactam antibiotics , 2003, Allergy.

[53]  P. Demoly,et al.  Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations , 2003, Allergy.

[54]  P. Demoly,et al.  General considerations for skin test procedures in the diagnosis of drug hypersensitivity , 2002, Allergy.

[55]  P. Demoly,et al.  Drug hypersensitivity: questionnaire , 1999 .

[56]  L. Mayorga,et al.  Basophil Activation Experiments in Immediate Drug Hypersensitivity: More Than a Diagnostic Aid. , 2020, Methods in molecular biology.

[57]  S. Mallal,et al.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. , 2018, The journal of allergy and clinical immunology. In practice.

[58]  K. Brockow.  Drug Allergy: Definitions and Phenotypes , 2018 .

[59]  R. Cernadas,et al.  In vitro tests for Drug Hypersensitivity Reactions . An ENDA / EAACI Drug Allergy Interest Group Position Paper , 2017 .

[60]  A. Bircher,et al.  Drug hypersensitivity reactions: Inconsistency in the use of the classification of immediate and nonimmediate reactions. , 2012, The Journal of allergy and clinical immunology.

[61]  P. Demoly,et al.  Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. , 1999, Allergy.